National Wire About Nigerians, Nigerian Business and Other Stories
Shareholders of GlaxoSmithKline Consumer Nigeria (GSK) Plc yesterday approved a dividend of 30 kobo per share recommended by the board of directors for the year ended December 31, 2016. The approval was given at the 46th annual general meeting (AGM) held in Lagos.
GSK recorded a turnover of N14.385 billion for 2016, while profit after tax (PAT) stood at N2.378 billion, up from N873 million in 2015.
Hence, the directors recommended the 30 kobo dividend per 50 kobo per share, which the shareholders approved and commended the directors for. They urged the board and management to continue to work tirelessly to take the company to greater heights and also produce a better result in the new financial year.
Speaking at the AGM, Chairman of the company, the divestment of the company’s drinks business in third quarter (Q3) enabled the company to align with the global strategy and focus on its core businesses with the aim of driving improved margins and sustainable growth.
